Is steroid receptor profile in contralateral breast cancer a marker of independence of the corresponding primary tumour?

European Journal of Cancer

Volumn 34, Issue 6, 1998, Pages 825-830

  Coradini, D ^a   Oriana, S ^a   Mariani, L ^a   Miceli, R ^a   Bresciani, G ^a   Marubini, E ^a,b   Di Fronzo, G ^a,c  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c CNR   (Italy)

Author keywords

Contralateral breast cancer; Oestrogen receptor; Progesterone receptor

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; BILATERAL CANCER; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER SURVIVAL; DIAGNOSTIC VALUE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; MENOPAUSE; MIDDLE AGED; NEOPLASMS, MULTIPLE PRIMARY; NEOPLASMS, SECOND PRIMARY; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; TUMOR MARKERS, BIOLOGICAL;

EID: 0032078259     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(97)10121-6     Document Type: Article

References (24)

1. Mueller CB, Ames F. Bilateral carcinoma of the breast: frequency and mortality. Cancer J Surg 1978, 21, 459-466.
2. Hislop TG, Elwood JM, Goldman AJ, Spinelli J, Worth AJ, Ellison LG. Second primary cancers of the breast: incidence and risk factors. Er J Cancer 1984, 49, 79-85.
3. Fracchia AA, Robinson D, Legaspi A. Survival in bilateral breast cancer. Cancer 1985, 55, 1414-1421.
4. Robbins GF, Berg JW. Bilateral primary breast cancers: a clinicopathological study. Cancer 1964, 17, 1501-1527.
5. Schell SR, Montague ED, Spanos WJ Jr, Tapley N, Fletcher GH, Oswald MJ. Bilateral breast cancer in patients with initial stage I and II disease. Cancer 1982, 50, 1191-1196.
6. Nielsen M, Christensen L, Andersen J. Contralateral cancerous breast lesions in women with clinical invasive breast carcinoma. Cancer 1986, 57, 897-902.
7. Bailey MJ, Royce C, Sloane JP, Ford HT, Powles TJ, Gazet J-C. Bilateral carcinoma of the breast. BrJ Surg 1980, 67, 514-516.
8. Prior R, Waterhouse JAH. The incidence of bilateral breast cancer: II. A proposed model for the analysis of coincidental tumours. BrJ Cancer 1981, 43, 615-622.
9. Webber BL, Heise H, Neifeld JP, Cost J. Risk of subsequent breast carcinoma in a population of patients with in situ breast carcinoma. Cancer 1981, 47, 2928-2932.
10. Kessler HJ, Grier WRN, Seidman I, Mcllveen SJ. Bilateral primary breast cancer. J Am Med Assoc 1976, 236, 278-280.
11. Del Turco MR, Ciatto S, Prigli G, Borrelli D, Carcangiu ML, Santucci M. Bilateral cancer of the breast. Tumori 1982, 68, 155-160.
12. Saetersdal A, Dorum A, Heimdal K, et al. Inherited predisposition. Results of first round examination of 537 women at risk. Anticancer Res 1996, 16, 1989-1992.
13. Ronchi E, Granata G, Brivio M, Coradini D, Miodini P, Di Fronzo G. A double-labeling assay for simultaneous estimation and characterization of estrogen and progesterone receptors using radioiodinated estradiol and tritiated Org 2058. Tumori 1986, 72, 251-257.
14. Mathiesen O, Bonderup O, Carl J, Panduro J, Pedersen KO. The prognostic value of estrogen and progesterone receptors in female breast cancer. Acta Oncol 1991, 30, 691-695.
15. Foote FW, Stewart FW. Comparative studies of cancerous versus non cancerous breasts, I and II. Ann Surg 1945, 191(Part I), 197(PartII).
16. Gallager HS, Martin J. Early phases in the development of breast cancer. Cancer 1969, 26, 1170-1178.
17. Al-Jurf AS, Jochimsen PR, Urdanetta LF, Scott D. Factors influencing survival in bilateral breast cancer. J Surg Oncol 1981, 16, 343-348.
18. Kiang DT, Kennedy BJ, Snover DC. Biological and histological characteristics of simultaneous bilateral breast cancer. Lancet 1980, 2, 1105-1108.
19. Coradini D, Oriana S, Ditto A, Bresciani G, Di Fronzo G. Receptor status variation in primary breast cancer and subsequent accessible relapse. Int J Oncol 1996, 8, 997-1002.
20. Di Fronzo G, Cappelletti V, Coradini D, Ronchi E, Scavone GF. Prognostic significance of progesterone receptors alone or in association with estrogen receptors in human breast cancer. Tumori 1984, 70, 159-164.
21. Rosen PP, Menendez-Botet CJ, Misselbaum JS, Urban JA, Mike V, Fracchia A, Schwanz MK. Pathological review of breast lesions analyzed for estrogen receptor protein. Cancer Res 1975, 25, 3187-3194.
22. Antoniades K, Spector H. Correlation of estrogen receptor levels with histology and cytomorphology in human mammary cancer. Am J Clin Pathol 1979, 71, 497-503.
23. Searle SR, Casella G, McCulloch CE. Variance Components. New York, John Wiley, 1992.
24. SAS Institute Inc, SAS Technical Report P-229, SAS/STAT Software: changes and enhancementes, Release 6.07, Cary, NC, SAS Institute Inc, 1992.